Sunday, 25 March 2012

BioMarin: Genzyme virus problem won

cahijisebi.wordpress.com
Genzyme (NASDAQ: GENZ) found a virus strain and stopper production of two drugs atthe Allston, Mass., The strain, Vesivirus 2117, apparently does not cause human infection but interrupts the growth of cellas that are used to make drugs. Aldurazyme — a treatmenft for MPS I, a rare and fatal disease caused by an enzymedeficiency — was last filledd at the Genzyme facility in Septembedr 2008, according to BioMarin (NASDAQ: The company has about 10 monthas of vialed inventory on hand, it said, and uses a secondx fill finish supplier. A third supplierr is expected to be qualified latetthis year, BioMarin said.
BioMarin makes the bulk materiapl used in Aldurazyme at its Novato The Food and Drug Administration hadinspected Genzyme’xs plant in September and October and reportedlyh was concerned about controls to protec t against contamination.

No comments:

Post a Comment